Finch Therapeutics receives fast track designation for investigation of Full-Spectrum Microbiota as treatment for children with autism spectrum disorder

Image: The US FDA’s Center for Drug Evaluation and Research. Photo: courtesy of The U.S. Food and Drug Administration.